These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 1968467)

  • 21. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
    Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
    J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptors.
    Kazmierski W; Wire WS; Lui GK; Knapp RJ; Shook JE; Burks TF; Yamamura HI; Hruby VJ
    J Med Chem; 1988 Nov; 31(11):2170-7. PubMed ID: 2903246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.
    Liebow C; Reilly C; Serrano M; Schally AV
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2003-7. PubMed ID: 2564678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of somatostatin analogs on prolactin secretion in rats pretreated with estrogen or haloperidol.
    Karashima T; Schally AV
    Proc Soc Exp Biol Med; 1987 May; 185(1):69-75. PubMed ID: 2883661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo.
    Kramer TH; Shook JE; Kazmierski W; Ayres EA; Wire WS; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 May; 249(2):544-51. PubMed ID: 2566679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin receptor subtype 3 mediates the inhibitory action of somatostatin on gastric smooth muscle cells.
    Gu ZF; Corleto VD; Mantey SA; Coy DH; Maton PN; Jensi RT
    Am J Physiol; 1995 May; 268(5 Pt 1):G739-48. PubMed ID: 7762657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of microcapsules of luteinizing hormone-releasing hormone antagonist SB-75 and somatostatin analog RC-160 on endocrine status and tumor growth in the Dunning R-3327H rat prostate cancer model.
    Yano T; Pinski J; Szepeshazi K; Milovanovic SR; Groot K; Schally AV
    Prostate; 1992; 20(4):297-310. PubMed ID: 1351672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, Cytotoxicity and Antioxidant Activity of New Analogs of RC-121 Synthetic Derivatives of Somatostatin.
    Naydenova E; Wesselinova D; Staykova S; Goshev I; Vezenkov L
    Anticancer Agents Med Chem; 2018; 18(10):1417-1424. PubMed ID: 29667555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional effects of D-Phe-c[Cys-Tyr-D-Trp-Lys-Val-Cys]-Trp-NH2 and differential changes in somatostatin receptor messenger RNAs, binding sites and somatostatin release in kainic acid-treated rats.
    Pérez J; Vezzani A; Civenni G; Tutka P; Rizzi M; Schüpbach E; Hoyer D
    Neuroscience; 1995 Apr; 65(4):1087-97. PubMed ID: 7617164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New specific radioligand for one subpopulation of brain somatostatin receptors.
    Reubi JC
    Life Sci; 1985 May; 36(19):1829-36. PubMed ID: 2859510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
    Hawkins KN; Knapp RJ; Lui GK; Gulya K; Kazmierski W; Wan YP; Pelton JT; Hruby VJ; Yamamura HI
    J Pharmacol Exp Ther; 1989 Jan; 248(1):73-80. PubMed ID: 2563293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting peptides for pleural cavity tumor radiotherapy: specificity and dosimetry of Re-188-RC-160.
    Zamora PO; Bender H; Knapp FF; Rhodes BA; Biersack HJ
    Hybridoma; 1997 Feb; 16(1):85-91. PubMed ID: 9085134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160.
    Milovanovic SR; Radulovic S; Groot K; Schally AV
    Prostate; 1992; 20(4):269-80. PubMed ID: 1376910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice.
    Radulovic S; Comaru-Schally AM; Milovanovic S; Schally AV
    Pancreas; 1993 Jan; 8(1):88-97. PubMed ID: 8093555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted cytotoxic analogue of somatostatin AN-238 inhibits growth of androgen-independent Dunning R-3327-AT-1 prostate cancer in rats at nontoxic doses.
    Koppan M; Nagy A; Schally AV; Arencibia JM; Plonowski A; Halmos G
    Cancer Res; 1998 Sep; 58(18):4132-7. PubMed ID: 9751625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of combination treatment with analogs of luteinizing hormone-releasing hormone (LH-RH) or somatostatin and 5-fluorouracil on pancreatic cancer in hamsters.
    Szepeshazi K; Lapis K; Schally AV
    Int J Cancer; 1991 Sep; 49(2):260-6. PubMed ID: 1679045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors.
    Reubi JC; Häcki WH; Lamberts SW
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1127-34. PubMed ID: 2824549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of N-nitrosobis(2-oxopropyl)amine-induced pancreatic cancer in Syrian golden hamsters with D-Trp-6-LH-RH and somatostatin analogue RC-160 microcapsules.
    Zalatnai A; Schally AV
    Cancer Res; 1989 Apr; 49(7):1810-5. PubMed ID: 2564312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238.
    Plonowski A; Schally AV; Nagy A; Sun B; Szepeshazi K
    Cancer Res; 1999 Apr; 59(8):1947-53. PubMed ID: 10213505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
    Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
    Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.